Month: November 2022

Yew Lee Posts RM6.1 Million Revenue in 3Q

acn

KUALA LUMPUR, Nov 30, 2022 – (ACN Newswire via SEAPRWire.com) – Yew Lee Pacific Group Berhad, a manufacturer of industrial brushes as well as trading of industrial hardware and machinery parts, today announced that the Group recorded revenue of RM6.10 million for the third quarter ended 30 September 2022 (3Q FY2022). Managing Director of Yew […]

MHI Publishes Integrated Report “MHI Report 2022”

jcn

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Heavy Industries, Ltd. (MHI) today published the “MHI Report 2022.” The focus of this year’s integrated report is on MHI Group’s contributions to global Carbon Neutrality. In October 2021, MHI announced its commitment to achieve Carbon Neutrality Groupwide by 2040, and MHI Report 2022 […]

XCLUSIVERSE Announces ‘Extend The Unlimited’ Event

seaprwire

Dubai, UAE, November 30, 2022 – (SEAPRWire) – XCLUSIVERSE will host ‘Extend The Unlimited’, an event aiming to become the largest ever mixed-reality live event, on December 5th. Mixed reality stands for interactions that combine physical and digital actions in order to obtain a result only possible through the implications of both worlds, and XCLUSIVERSE promises to deliver […]

AEON Credit Secures its Framework for Sustainability-Linked Loans, Strengthens and Advances its Sustainability Pledge

acn

HONG KONG, Nov 30, 2022 – (ACN Newswire via SEAPRWire.com) – AEON Credit Service (Asia) Company Limited (“AEON Credit” or the “Group”; Stock Code: 00900) today announced that it has secured its sustainability-linked loan framework and entered agreements for three sustainability-linked loans (the “Loans”), with Mizuho Bank, Ltd., Hong Kong Branch, MUFG Bank, Ltd., Japanese […]

NEC Orchestrating Future Fund, an Ecosystem-type CVC Fund, Completes Final Close for US$140 Million

jcn

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (TSE: 6701) has completed the final close of the “NEC Orchestrating Future Fund”(1), an ecosystem-type corporate venture capital (CVC) fund established in December 2021 for US$140 million (approximately 20 billion yen). This CVC fund was made possible through investments from NTT FINANCE CORPORATION, […]

Titan Projects 10x Business Growth in 2022 since Partnering with aCommerce in the Philippines

acn

BANGKOK & MANILA, Nov 30, 2022 – (ACN Newswire via SEAPRWire.com) – As the first and only basketball specialty concept store in the Philippines, Titan started as a brick-and-mortar retail business in 2010. The retailer established stores in posh locations and around the metropolis, such as Bonifacio Global City, Megamall, Conrad, Vertis, Alabang, and Solenad. […]

Poh Heng Encapsulates Women Empowerment with its Latest Freestyle Collection

acn

SINGAPORE, Nov 30, 2022 – (ACN Newswire via SEAPRWire.com) – Poh Heng Jewellery, Singapore’s hallmark jewellery brand, is celebrating women and freedom of expression with the latest addition to its Freestyle collection. Inspired by modern women, the bolt designs symbolise power and strength, while the bling designs represent expression of style, success and aspirations. Encased […]

ExxonMobil, Mitsubishi Heavy Industries Form Carbon Capture Technology Alliance

jcn

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – ExxonMobil and Mitsubishi Heavy Industries (MHI) have joined forces to deploy MHI’s leading CO2 capture technology as part of ExxonMobil’s end-to-end carbon capture and storage (CCS) solution for industrial customers. The joint effort combines ExxonMobil’s and MHI’s years of expertise in the industry and strengthens […]

Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

jcn

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s […]

Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease in the New England Journal of Medicine

jcn

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s […]